ADVANCED ACCELERATOR APPLICATIONS USA INC

Federal contract awards won by ADVANCED ACCELERATOR APPLICATIONS USA INC (UEI JNM4NBNHFE66), 2018–2026 — public record from USAspending.

Showing awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

79
awards
4
expiring in 12 months
2
agencies

How their work has changed

Mostly the same kind of work as two years ago.

Share of their contracts in each industry code: the last 24 months compared with the 24 months before, as of Nov 18, 2026. Shown only for companies with at least 5 contracts in each period.

Category award history

128 category awards to a new vendor (same agency and NAICS code, not this contract's own history) — latest: CENTRAL ADMIXTURE PHARMACY SERVICES, INC took Department of Veterans Affairs 325412 work from ADVANCED ACCELERATOR APPLICATIONS USA INC (Nov 16, 2026).

Agencies buying from ADVANCED ACCELERATOR APPLICATIONS USA INC

Awards

VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
Department of Veterans Affairs · $960,239 · Oct 1, 2026
PLUVICTO AND LUTATHERA
Department of Veterans Affairs · $1,200,000 · Feb 17, 2026
RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML.
Department of Veterans Affairs · $996,874 · Jan 1, 2026
VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
Department of Veterans Affairs · $5,075,550 · Dec 20, 2025
PLUVICTO AND LUTATHERA
Department of Veterans Affairs · $1,362,395 · Feb 17, 2025
RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML.
Department of Veterans Affairs · No current value reported · Jan 1, 2025
VA PHOENIX PLUVICTO
Department of Veterans Affairs · $993,273 · Jan 1, 2025
LUTETIUM - PLUVICTO AND LUTATHERA
Department of Veterans Affairs · $2,329,881 · Jan 1, 2025
LUTATHERA & PLUVICTO ISOTOPES
Department of Veterans Affairs · $1,934,973 · Jan 1, 2025
RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML.
Department of Veterans Affairs · $993,273 · Jan 1, 2025
PURCHASE OF MEDICATION ON AN 'AS-NEEDED' BASIS FOR 8 MONTHS.
Department of Veterans Affairs · $731,041 · Jan 1, 2025
VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
Department of Veterans Affairs · $498,437 · Dec 20, 2024
VISN PADIOPHARMACEUTICAL PLUVICTO DRUG
Department of Veterans Affairs · No current value reported · Dec 20, 2024
SIX BRANDED NUCLEAR MEDICINE FDA APPROVED LUTATHERA AND PLUVICTO.
Department of Defense · $498,438 · Dec 4, 2024
PLUVICTO AND LUTATHERA FY 25
Department of Veterans Affairs · $4,076,022 · Nov 1, 2024
PLUVICTO RADIOPHARM
Department of Veterans Affairs · $1,095,121 · Nov 1, 2024
PLUVICTO DO/TO
Department of Veterans Affairs · $298,822 · Oct 28, 2024
PLUVICTO PROSTATE CANCER THERAPY VANCHCS
Department of Veterans Affairs · $2,158,213 · Oct 1, 2024
LUTATHERA (LUTETIUM LU 177 DOTATATE)
Department of Veterans Affairs · $679,949 · Oct 1, 2024
PLUVICTO
Department of Veterans Affairs · $1,062,252 · Oct 1, 2024
PLUVICTO AND LUTATHERA INJECTION
Department of Defense · No current value reported · Oct 1, 2024
PLUVICTO
Department of Veterans Affairs · $1,986,545 · Oct 1, 2024
PLUVICTO? (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN)
Department of Veterans Affairs · $1,063,332 · Oct 1, 2024
PLUVICTO
Department of Veterans Affairs · No current value reported · Oct 1, 2024
DELIVERY ORDER FOR PLUVICTO AND LUTATHERA
Department of Defense · $3,387,020 · Oct 1, 2024